Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
about
Poxvirus cell entry: how many proteins does it take?Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansEfalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindranceStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 ProteinThe membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsThe myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entryNorovirus GII.4 strain antigenic variationDNA vaccines for biodefense.Smallpox vaccines: targets of protective immunity.Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry.Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.Poxvirus proteomics and virus-host protein interactions.Membrane fusion during poxvirus entry.Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8.Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex
P2860
Q27002455-FC345415-21BE-4427-90C7-91C3022D111FQ27488704-A03FBAB1-8708-4837-B258-2EA86645E81AQ27654007-47AD961A-7406-4364-9240-9FB70AE84E0FQ27679281-C02DD64E-9522-4E8A-9C1F-0D3B56FF0A51Q27684713-7899EC3B-0E22-48CA-BE5A-77E749D7A5D7Q34109783-328A9360-905F-4AAB-9FA0-4406A3BF21E9Q34259469-3194ED7E-256D-4CC7-98AA-E950F2861DE2Q34457831-4B42238D-4FA7-45C8-96A2-6B23EB6168A9Q34614260-D0EC103A-BDC4-4B32-8CE7-95BFFFD3B1C2Q34780607-0A2A5160-C753-460B-A337-8A45583565BBQ34799960-B85A2B04-44E4-435E-855F-2F7D6D56C0A6Q35226200-974130CF-7B79-47B1-A543-3F1728865C49Q35339702-69775197-70D0-4D0C-B006-BAB5BDF16531Q35760869-D3B992E6-0B44-4536-9665-C84A693C9753Q35998125-86AF2BBE-9A53-496A-864E-9C4907353B59Q36845650-C33E7E31-657E-448D-8537-F77075C5ED7AQ37125302-1FDE13D7-6E49-4278-9300-62922016C7E5Q37359610-B92F843C-AAC3-4DC4-8102-47BCC7D7BA63Q37461110-5856E44B-03B0-489E-839B-A87B71CBA4E5Q37640977-343D2CBF-14FC-4A27-86DF-30D90A183603Q38899115-B9850BE0-2C99-42FF-AD44-97C643BC4DF3Q45325021-B3D9F7E6-501B-4A26-9937-1E432C6C6E80Q55714396-C0EB8104-B3D0-48D7-9486-4291295EE058Q59127072-09E0D099-3608-481B-82CB-D68367F8A8BC
P2860
Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@ast
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@en
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@nl
type
label
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@ast
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@en
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@nl
prefLabel
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@ast
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@en
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@nl
P2093
P2860
P1433
P1476
Structural basis for the bindi ...... 11, to the poxvirus L1 protein
@en
P2093
Apostolos G Gittis
David N Garboczi
Hua-Poo Su
P2860
P304
P356
10.1016/J.VIROL.2007.06.042
P407
P577
2007-08-03T00:00:00Z